The 833,684 outstanding warrants of Cingulate Inc. (US:CING) reported as of June 30, 2025, represent a potential source of future dilution, though their immediate impact is currently limited.
Here's an analysis of their potential impact:
- Current Status and Exercise Prices: As of June 30, 2025, Cingulate Inc. reported 833,684 warrants outstanding across various series.1 The exercise prices for these warrants range significantly, from $7.02 to $1,800.00 per share.1 Given that CING's common stock was trading at $5.17 per share on July 18, 2025,2 all of these warrants were "out-of-the-money" at that time. This means their exercise price was higher than the market price, making it economically unfavorable for holders to exercise them.
- Interpretation of "June 30, 2025": The phrasing "outstanding warrants (June 30, 2025)" in your question likely refers to the balance of warrants reported as of that date in the company's SEC filings.1 If these warrants genuinely expired on June 30, 2025, and were out-of-the-money, they would have expired worthless and would no longer pose a dilution risk. However, the reporting of them as "outstanding" in a 10-Q filed after that date suggests their actual expiration dates extend beyond June 30, 2025.
- Potential Future Dilution: The potential for future dilution hinges on Cingulate's stock price increasing above the warrants' respective exercise prices before their actual expiration dates. The most significant block of warrants with lower exercise prices includes 354,167 Series C warrants and 177,083 Series D warrants, both with an exercise price of $7.02.1 If the stock price rises above $7.02, these 531,250 warrants would become "in-the-money" and could be exercised, leading to dilution.
- Maximum Dilution Scenario: As of June 30, 2025, Cingulate Inc. had 4,889,290 shares of common stock issued and outstanding.1 If all 833,684 warrants were to be exercised, the total number of common shares outstanding would increase to 5,722,974 (4,889,290 + 833,684). This would represent a potential dilution of approximately 17.05% (833,684 / 4,889,290) to existing shareholders. This dilution would impact earnings per share (EPS) and other per-share metrics.
In summary, while the warrants currently pose no immediate dilution threat due to being out-of-the-money, they represent a significant overhang that could dilute shareholder value if the company's stock price appreciates sufficiently in the future.
